Holen Sie sich die Stockscreener-App
5.12
1.16%
-0.06
Schlusskurs vom Vortag:
$5.18
Offen:
$5.31
24-Stunden-Volumen:
438.43K
Relative Volume:
1.08
Marktkapitalisierung:
$197.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-42.05M
KGV:
-1.8156
EPS:
-2.82
Netto-Cashflow:
$-35.26M
1W Leistung:
+0.00%
1M Leistung:
+3.23%
6M Leistung:
+43.02%
1J Leistung:
+107.29%
1-Tages-Spanne:
$4.91
$5.34
1-Wochen-Bereich:
$4.91
$5.39
52-Wochen-Spanne:
$2.21
$10.48
Protara Therapeutics Inc Stock (TARA) Company Profile
Firmenname
Protara Therapeutics Inc
Sektor
Branche
Telefon
646-844-0337
Adresse
345 PARK AVENUE SOUTH, NEW YORK, NY
Vergleichen Sie TARA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TARA
Protara Therapeutics Inc
|
5.12 | 199.85M | 0 | -42.05M | -35.26M | -2.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Protara Therapeutics Inc Stock (TARA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-03-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-10 | Fortgesetzt | Guggenheim | Buy |
| 2021-06-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-02-17 | Eingeleitet | Oppenheimer | Outperform |
| 2020-10-19 | Eingeleitet | Cowen | Outperform |
| 2020-07-29 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Protara Therapeutics Inc Aktie (TARA) Neueste Nachrichten
Published on: 2025-11-04 00:31:20 - newser.com
Will Protara Therapeutics Inc. stock deliver long term returnsWeekly Profit Recap & Verified High Yield Trade Plans - newser.com
Why Protara Therapeutics Inc. (1KPA) stock is listed among top recommendationsMarket Movement Recap & Safe Entry Momentum Tips - newser.com
Will Protara Therapeutics Inc. stock attract more institutional investors2025 Geopolitical Influence & Free Technical Pattern Based Buy Signals - newser.com
Will Protara Therapeutics Inc. stock benefit from upcoming earnings reports2025 Retail Activity & Safe Investment Capital Preservation Plans - newser.com
Chart based analysis of Protara Therapeutics Inc. trendsJuly 2025 Big Picture & Reliable Entry Point Trade Alerts - newser.com
How Protara Therapeutics Inc. (1KPA) stock reacts to fiscal policies2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Why Protara Therapeutics Inc. (1KPA) stock fits value portfolios2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Visualizing Protara Therapeutics Inc. stock with heatmaps2025 Year in Review & Free Expert Verified Stock Movement Alerts - newser.com
Real time pattern detection on Protara Therapeutics Inc. stockGold Moves & AI Enhanced Trading Signals - newser.com
Why Protara Therapeutics Inc. stock appeals to analystsWeekly Risk Report & Risk Controlled Daily Plans - newser.com
Can Protara Therapeutics Inc. (1KPA) stock attract analyst upgradesMarket Sentiment Summary & Daily Profit Focused Stock Screening - newser.com
What recovery options are there for Protara Therapeutics Inc.Oil Prices & Smart Swing Trading Alerts - newser.com
Is Protara Therapeutics Inc. stock a safe haven assetVolume Spike & Daily Volume Surge Signals - newser.com
Can technical indicators confirm Protara Therapeutics Inc.’s reversalTrade Analysis Report & Daily Risk Controlled Trade Plans - newser.com
Risk adjusted return profile for Protara Therapeutics Inc. analyzedJuly 2025 Recap & Safe Investment Capital Preservation Plans - newser.com
What is the fair value estimate for Protara Therapeutics Inc. (1KPA) stock in 20252025 Sector Review & Proven Capital Preservation Methods - newser.com
Protara Therapeutics, Inc. (NASDAQ:TARA) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Will Protara Therapeutics Inc. stock rally after Fed decisionsJuly 2025 PreEarnings & Capital Efficient Trade Techniques - newser.com
What analysts say about Protara Therapeutics Inc stockGlobal Trade Effects & Small Entry Investment Ideas - earlytimes.in
Is NINtec Systems Limited Stock Poised for a Breakout in YEARSupport and Resistance Levels & Affordable Growth Trading - earlytimes.in
Protara Therapeutics (NASDAQ:TARA) Trading Down 1.2%Here's What Happened - MarketBeat
Long term hold vs stop loss in Protara Therapeutics Inc.July 2025 Reactions & Daily Profit Focused Screening - newser.com
How Protara Therapeutics Inc. stock trades during market volatilityWeekly Profit Analysis & AI Forecasted Stock Moves - newser.com
How to read the order book for Protara Therapeutics Inc.July 2025 Update & Safe Entry Point Alerts - newser.com
Will Protara Therapeutics Inc. price bounce be sustainable2025 Market WrapUp & High Accuracy Swing Entry Alerts - newser.com
Measuring Protara Therapeutics Inc.’s beta against major indicesQuarterly Growth Report & Capital Efficient Trading Techniques - newser.com
Is Protara Therapeutics Inc. (1KPA) stock inflation resilient2025 Volatility Report & AI Powered Trade Plan Recommendations - newser.com
Finanzdaten der Protara Therapeutics Inc-Aktie (TARA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):